{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:55:49Z","timestamp":1794718549970,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":99,"publisher":"Springer US","isbn-type":[{"value":"9781071626344","type":"print"},{"value":"9781071626351","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2635-1_21","type":"book-chapter","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:04:11Z","timestamp":1664460251000},"page":"321-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influenza A Virus Neuraminidase Inhibitors"],"prefix":"10.1007","author":[{"given":"Nongluk","family":"Sriwilaijaroen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Vavricka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"21_CR1","unstructured":"ICTV Website (2021) Virus taxonomy: 2020 release. https:\/\/talk.ictvonline.org\/ictv-reports\/ictv_9th_report\/negative-sense-rna-viruses-2011\/w\/negrna_viruses\/209\/orthomyxoviridae"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"S Tong","year":"2013","unstructured":"Tong S, Zhu X, Li Y et al (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog 9:e1003657","journal-title":"PLoS Pathog"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/vaccines8040587","volume":"8","author":"N Sriwilaijaroen","year":"2020","unstructured":"Sriwilaijaroen N, Suzuki Y (2020) Host receptors of influenza viruses and coronaviruses-molecular mechanisms of recognition. Vaccines (Basel) 8:587","journal-title":"Vaccines (Basel)"},{"key":"21_CR4","unstructured":"WHO Website (2021) Influenza \u2013 estimating burden of disease. https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/seasonal-influenza\/burden-of-influenza"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"111841","DOI":"10.1016\/j.ejmech.2019.111841","volume":"185","author":"K Wang","year":"2020","unstructured":"Wang K, Lei Z, Zhao L et al (2020) Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A. Eur J Med Chem 185:111841","journal-title":"Eur J Med Chem"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2019.08.010","volume":"28","author":"E de Vries","year":"2020","unstructured":"de Vries E, Du W, Guo H et al (2020) Influenza A virus hemagglutinin-neuraminidase-receptor balance: preserving virus motility. Trends Microbiol 28:57\u201367","journal-title":"Trends Microbiol"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6468(08)70044-4","volume":"36","author":"MJ Kiefel","year":"1999","unstructured":"Kiefel MJ, von Itzstein M (1999) Influenza virus sialidase: a target for drug discovery. Prog Med Chem 36:1\u201328","journal-title":"Prog Med Chem"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M von Itzstein","year":"1993","unstructured":"von Itzstein M, Wu WY, Kok GB et al (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418\u2013423","journal-title":"Nature"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/ja963036t","volume":"119","author":"CU Kim","year":"1997","unstructured":"Kim CU, Lew W, Williams MA et al (1997) Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 119:681\u2013690","journal-title":"J Am Chem Soc"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1021\/jm0002679","volume":"43","author":"YS Babu","year":"2000","unstructured":"Babu YS, Chand P, Bantia S et al (2000) BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem 43:3482\u20133486","journal-title":"J Med Chem"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/AAC.00333-08","volume":"53","author":"M Yamashita","year":"2009","unstructured":"Yamashita M, Tomozawa T, Kakuta M et al (2009) CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother 53:186\u2013192","journal-title":"Antimicrob Agents Chemother"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"13254","DOI":"10.1021\/ja405916q","volume":"135","author":"FS Shidmoossavee","year":"2013","unstructured":"Shidmoossavee FS, Watson JN, Bennet AJ (2013) Chemical insight into the emergence of influenza virus strains that are resistant to Relenza. J Am Chem Soc 135:13254\u201313257","journal-title":"J Am Chem Soc"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1056\/NEJMp058291","volume":"353","author":"A Moscona","year":"2005","unstructured":"Moscona A (2005) Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 353:2633\u20132636","journal-title":"N Engl J Med"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01200-09","volume":"83","author":"AC Hurt","year":"2009","unstructured":"Hurt AC, Holien JK, Parker M et al (2009) Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol 83:10366\u201310373","journal-title":"J Virol"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.18388\/abp.2014_1871","volume":"61","author":"A Nitsch-Osuch","year":"2014","unstructured":"Nitsch-Osuch A, Brydak LB (2014) Influenza viruses resistant to neuraminidase inhibitors. Acta Biochim Pol 61:505\u2013508","journal-title":"Acta Biochim Pol"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1086\/651605","volume":"50","author":"MJ Memoli","year":"2010","unstructured":"Memoli MJ, Hrabal RJ, Hassantoufighi A et al (2010) Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis 50:1252\u20131255","journal-title":"Clin Infect Dis"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/infdis\/jiv288","volume":"212","author":"AG L\u2019Huillier","year":"2015","unstructured":"L\u2019Huillier AG, Abed Y, Petty TJ et al (2015) E119D neuraminidase mutation conferring pan-resistance to neuraminidase inhibitors in an A(H1N1)pdm09 isolate from a stem-cell transplant recipient. J Infect Dis 212:1726\u20131734","journal-title":"J Infect Dis"},{"key":"21_CR18","first-page":"95","volume-title":"Influenza virology: current topics","author":"MN Matrosovich","year":"2006","unstructured":"Matrosovich MN, Klenk HD, Kawaoka Y (2006) Receptor specificity, host-range, and pathogenicity of influenza viruses. In: Kawaoka Y (ed) Influenza virology: current topics. Caister Academic Press, Wymondham, pp 95\u2013137"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/978-1-0716-0430-4_47","volume":"2132","author":"N Sriwilaijaroen","year":"2020","unstructured":"Sriwilaijaroen N, Suzuki Y (2020) Sialoglycovirology of lectins: sialyl glycan binding of enveloped and non-enveloped viruses. Methods Mol Biol 2132:483\u2013545","journal-title":"Methods Mol Biol"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/mi.2017.16","volume":"10","author":"JL McAuley","year":"2017","unstructured":"McAuley JL, Corcilius L, Tan HX et al (2017) The cell surface mucin MUC1 limits the severity of influenza A virus infection. Mucosal Immunol 10:1581\u20131593","journal-title":"Mucosal Immunol"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich MN, Matrosovich TY, Gray T et al (2004) Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78:12665\u201312667","journal-title":"J Virol"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.micinf.2005.12.008","volume":"8","author":"M Ohuchi","year":"2006","unstructured":"Ohuchi M, Asaoka N, Sakai T et al (2006) Roles of neuraminidase in the initial stage of influenza virus infection. Microbes Infect 8:1287\u20131293","journal-title":"Microbes Infect"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","volume":"10","author":"JL McAuley","year":"2019","unstructured":"McAuley JL, Gilbertson BP, Trifkovic S et al (2019) Influenza virus neuraminidase structure and functions. Front Microbiol 10:39","journal-title":"Front Microbiol"},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1875398101205010002","volume":"5","author":"H Yagi","year":"2012","unstructured":"Yagi H, Watanabe S, Suzuki T et al (2012) Comparative analyses of N-glycosylation profiles of influenza A viruses grown in different host cells. Open Glycosci 5:2\u201312","journal-title":"Open Glycosci"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1099\/0022-1317-33-1-159","volume":"33","author":"P Palese","year":"1976","unstructured":"Palese P, Compans RW (1976) Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 33:159\u2013163","journal-title":"J Gen Virol"},{"key":"21_CR26","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1128\/JVI.00697-12","volume":"86","author":"R Xu","year":"2012","unstructured":"Xu R, Zhu X, McBride R et al (2012) Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J Virol 86:9221\u20139232","journal-title":"J Virol"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"e1008816","DOI":"10.1371\/journal.ppat.1008816","volume":"16","author":"W Du","year":"2020","unstructured":"Du W, Wolfert MA, Peeters B et al (2020) Mutation of the second sialic acid-binding site of influenza A virus neuraminidase drives compensatory mutations in hemagglutinin. PLoS Pathog 16:e1008816","journal-title":"PLoS Pathog"},{"key":"21_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1074\/jbc.M112.424150","volume":"288","author":"DV da Silva","year":"2013","unstructured":"da Silva DV, Nordholm J, Madjo U et al (2013) Assembly of subtype 1 influenza neuraminidase is driven by both the transmembrane and head domains. J Biol Chem 288:644\u2013653","journal-title":"J Biol Chem"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"8431","DOI":"10.1128\/JVI.00638-11","volume":"85","author":"M Wang","year":"2011","unstructured":"Wang M, Qi J, Liu Y et al (2011) Influenza A virus N5 neuraminidase has an extended 150-cavity. J Virol 85:8431\u20138435","journal-title":"J Virol"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.1128\/JVI.00805-14","volume":"88","author":"X Sun","year":"2014","unstructured":"Sun X, Li Q, Wu Y et al (2014) Structure of influenza virus N7: the last piece of the neuraminidase \u201cjigsaw\u201d puzzle. J Virol 88:9197\u20139207","journal-title":"J Virol"},{"key":"21_CR31","doi-asserted-by":"publisher","first-page":"e01243\u201318","DOI":"10.1128\/JVI.01243-18","volume":"92","author":"W Du","year":"2018","unstructured":"Du W, Dai M, Li Z et al (2018) Substrate binding by the second sialic acid-binding site of influenza A virus N1 neuraminidase contributes to enzymatic activity. J Virol 92:e01243\u201318","journal-title":"J Virol"},{"key":"21_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1021\/acscentsci.9b01071","volume":"6","author":"JD Durrant","year":"2020","unstructured":"Durrant JD, Kochanek SE, Casalino L et al (2020) Mesoscale all-atom influenza virus simulations suggest new substrate binding mechanism. ACS Cent Sci 6:189\u2013196","journal-title":"ACS Cent Sci"},{"key":"21_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/jm00031a011","volume":"37","author":"NR Taylor","year":"1994","unstructured":"Taylor NR, von Itzstein M (1994) Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J Med Chem 37:616\u2013624","journal-title":"J Med Chem"},{"key":"21_CR34","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/ncomms2487","volume":"4","author":"CJ Vavricka","year":"2013","unstructured":"Vavricka CJ, Liu Y, Kiyota H et al (2013) Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors. Nat Commun 4:1491","journal-title":"Nat Commun"},{"key":"21_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature05114","volume":"443","author":"RJ Russell","year":"2006","unstructured":"Russell RJ, Haire LF, Stevens DJ et al (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45\u201349","journal-title":"Nature"},{"key":"21_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ncomms1390","volume":"2","author":"RE Amaro","year":"2011","unstructured":"Amaro RE, Swift RV, Votapka L et al (2011) Mechanism of 150-cavity formation in influenza neuraminidase. Nat Commun 2:388","journal-title":"Nat Commun"},{"key":"21_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1476-5381.1966.tb01673.x","volume":"27","author":"JD Edmond","year":"1966","unstructured":"Edmond JD, Johnston RG, Kidd D et al (1966) The inhibition of neuraminidase and antiviral action. Br J Pharmacol Chemother 27:415\u2013426","journal-title":"Br J Pharmacol Chemother"},{"key":"21_CR38","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/BF00903465","volume":"100","author":"P Meindl","year":"1969","unstructured":"Meindl P, Tuppy H (1969) 2-Deoxy-2,3-dehydrosialic acids. I. Synthesis and properties of 2-deoxy-2,3-dehydro-N-acylneuraminic acids and their methyl esters. Monatsh Chem 100:1295\u20131306","journal-title":"Monatsh Chem"},{"key":"21_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0042-6822(74)90080-4","volume":"58","author":"P Meindl","year":"1974","unstructured":"Meindl P, Bodo G, Palese P et al (1974) Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 58:457\u2013463","journal-title":"Virology"},{"key":"21_CR40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/0042-6822(74)90458-9","volume":"59","author":"P Palese","year":"1974","unstructured":"Palese P, Schulman JL, Bodo G et al (1974) Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology 59:490\u2013498","journal-title":"Virology"},{"key":"21_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/303041a0","volume":"303","author":"PM Colman","year":"1983","unstructured":"Colman PM, Varghese JN, Laver WG (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41\u201344","journal-title":"Nature"},{"key":"21_CR42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","volume":"6","author":"JN Varghese","year":"1998","unstructured":"Varghese JN, Smith PW, Sollis SL et al (1998) Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6:735\u2013746","journal-title":"Structure"},{"key":"21_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/prot.340140302","volume":"14","author":"JN Varghese","year":"1992","unstructured":"Varghese JN, McKimm-Breschkin JL, Caldwell JB et al (1992) The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14:327\u2013332","journal-title":"Proteins"},{"key":"21_CR44","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1021\/acs.jmedchem.5b01863","volume":"59","author":"N Sriwilaijaroen","year":"2016","unstructured":"Sriwilaijaroen N, Magesh S, Imamura A et al (2016) A novel potent and highly specific inhibitor against influenza viral N1-N9 neuraminidases: insight into neuraminidase-inhibitor interactions. J Med Chem 59:4563\u20134577","journal-title":"J Med Chem"},{"key":"21_CR45","unstructured":"PHE Website (2019) PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/833572\/PHE_guidance_antivirals_influenza_201920.pdf"},{"key":"21_CR46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrd2400","volume":"6","author":"M von Itzstein","year":"2007","unstructured":"von Itzstein M (2007) The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 6:967\u2013974","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 1","key":"21_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199936001-00001","volume":"36","author":"LM Cass","year":"1999","unstructured":"Cass LM, Efthymiopoulos C, Bye A (1999) Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet 36(Suppl 1):1\u201311","journal-title":"Clin Pharmacokinet"},{"key":"21_CR48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/0929867003374886","volume":"7","author":"W Lew","year":"2000","unstructured":"Lew W, Chen X, Kim CU (2000) Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. Curr Med Chem 7:663\u2013672","journal-title":"Curr Med Chem"},{"key":"21_CR49","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/srep01551","volume":"3","author":"Y Wu","year":"2013","unstructured":"Wu Y, Qin G, Gao F et al (2013) Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding. Sci Rep 3:1551","journal-title":"Sci Rep"},{"key":"21_CR50","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1021\/jm010277p","volume":"44","author":"P Chand","year":"2001","unstructured":"Chand P, Kotian PL, Dehghani A et al (2001) Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity. J Med Chem 44:4379\u20134392","journal-title":"J Med Chem"},{"key":"21_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/135965350501000805","volume":"10","author":"L Barroso","year":"2005","unstructured":"Barroso L, Treanor J, Gubareva L et al (2005) Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Antivir Ther 10:901\u2013910","journal-title":"Antivir Ther"},{"key":"21_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3389\/fmicb.2016.00450","volume":"7","author":"MM Alame","year":"2016","unstructured":"Alame MM, Massaad E, Zaraket H (2016) Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections. Front Microbiol 7:450","journal-title":"Front Microbiol"},{"key":"21_CR53","unstructured":"PDR Website (2021) Peramivir \u2013 drug summary. https:\/\/www.pdr.net\/drug-summary\/Rapivab-peramivir-3660"},{"key":"21_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/irv.12046","volume":"7","author":"MG Ison","year":"2013","unstructured":"Ison MG (2013) Clinical use of approved influenza antivirals: therapy and prophylaxis. Influenza Other Respir Viruses 7:7\u201313","journal-title":"Influenza Other Respir Viruses"},{"key":"21_CR55","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/656802","volume":"51","author":"A Watanabe","year":"2010","unstructured":"Watanabe A, Chang SC, Kim MJ et al (2010) Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial. Clin Infect Dis 51:1167\u20131175","journal-title":"Clin Infect Dis"},{"key":"21_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1124\/dmd.112.048280","volume":"41","author":"K Koyama","year":"2013","unstructured":"Koyama K, Nakai D, Takahashi M et al (2013) Pharmacokinetic mechanism involved in the prolonged high retention of laninamivir in mouse respiratory tissues after intranasal administration of its prodrug laninamivir octanoate. Drug Metab Dispos 41:180\u2013187","journal-title":"Drug Metab Dispos"},{"key":"21_CR57","first-page":"539245","volume":"2011","author":"S Magesh","year":"2011","unstructured":"Magesh S, Sriwilaijaroen N, Moriya S et al (2011) Evaluation of a set of C9 N-acyl Neu5Ac2en mimetics as viral sialidase selective inhibitors. Int J Med Chem 2011:539245","journal-title":"Int J Med Chem"},{"key":"21_CR58","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.1128\/JVI.01703-16","volume":"90","author":"Y Wu","year":"2016","unstructured":"Wu Y, Gao F, Qi J et al (2016) Resistance to mutant group 2 influenza virus neuraminidases of an oseltamivir-zanamivir hybrid inhibitor. J Virol 90:10693\u201310700","journal-title":"J Virol"},{"key":"21_CR59","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1038\/srep02871","volume":"3","author":"PS Kerry","year":"2013","unstructured":"Kerry PS, Mohan S, Russell RJ et al (2013) Structural basis for a class of nanomolar influenza A neuraminidase inhibitors. Sci Rep 3:2871","journal-title":"Sci Rep"},{"key":"21_CR60","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1128\/AAC.00344-08","volume":"52","author":"K Hata","year":"2008","unstructured":"Hata K, Koseki K, Yamaguchi K et al (2008) Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother 52:3484\u20133491","journal-title":"Antimicrob Agents Chemother"},{"key":"21_CR61","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.bmc.2017.03.052","volume":"25","author":"Z Li","year":"2017","unstructured":"Li Z, Meng Y, Xu S et al (2017) Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors. Bioorg Med Chem 25:2772\u20132781","journal-title":"Bioorg Med Chem"},{"key":"21_CR62","doi-asserted-by":"publisher","first-page":"7532","DOI":"10.1021\/ja0344967","volume":"125","author":"AG Watts","year":"2003","unstructured":"Watts AG, Damager I, Amaya ML et al (2003) Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile. J Am Chem Soc 125:7532\u20137533","journal-title":"J Am Chem Soc"},{"key":"21_CR63","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1074\/jbc.M710247200","volume":"283","author":"SL Newstead","year":"2008","unstructured":"Newstead SL, Potter JA, Wilson JC et al (2008) The structure of Clostridium perfringens NanI sialidase and its catalytic intermediates. J Biol Chem 283:9080\u20139088","journal-title":"J Biol Chem"},{"key":"21_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.1232552","volume":"340","author":"JH Kim","year":"2013","unstructured":"Kim JH, Resende R, Wennekes T et al (2013) Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science 340:71\u201375","journal-title":"Science"},{"key":"21_CR65","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/anie.201412243","volume":"54","author":"L Dirr","year":"2015","unstructured":"Dirr L, El-Deeb IM, Guillon P et al (2015) The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed. Angew Chem Int Ed Engl 54:2936\u20132940","journal-title":"Angew Chem Int Ed Engl"},{"key":"21_CR66","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1038\/s41598-017-07836-y","volume":"7","author":"CJ Vavricka","year":"2017","unstructured":"Vavricka CJ, Muto C, Hasunuma T et al (2017) Synthesis of sulfo-sialic acid analogues: potent neuraminidase inhibitors in regards to anomeric functionality. Sci Rep 7:8239","journal-title":"Sci Rep"},{"key":"21_CR67","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1039\/C7OB00947J","volume":"15","author":"A Hadhazi","year":"2017","unstructured":"Hadhazi A, Pascolutti M, Bailly B et al (2017) A sialosyl sulfonate as a potent inhibitor of influenza virus replication. Org Biomol Chem 15:5249\u20135253","journal-title":"Org Biomol Chem"},{"key":"21_CR68","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cmdc.201800092","volume":"13","author":"A Hadhazi","year":"2018","unstructured":"Hadhazi A, Li L, Bailly B et al (2018) A sulfonozanamivir analogue has potent anti-influenza virus activity. ChemMedChem 13:785\u2013789","journal-title":"ChemMedChem"},{"key":"21_CR69","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.bmc.2004.01.013","volume":"12","author":"K Sasaki","year":"2004","unstructured":"Sasaki K, Nishida Y, Kambara M et al (2004) Design of N-acetyl-6-sulfo-b-D-glucosaminide-based inhibitors of influenza virus sialidase. Bioorg Med Chem 12:1367\u20131375","journal-title":"Bioorg Med Chem"},{"key":"21_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/ncomms1114","volume":"1","author":"S Rudrawar","year":"2010","unstructured":"Rudrawar S, Dyason JC, Rameix-Welti MA et al (2010) Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase. Nat Commun 1:113","journal-title":"Nat Commun"},{"key":"21_CR71","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1039\/c2ob25627d","volume":"10","author":"S Rudrawar","year":"2012","unstructured":"Rudrawar S, Kerry PS, Rameix-Welti MA et al (2012) Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility. Org Biomol Chem 10:8628\u20138639","journal-title":"Org Biomol Chem"},{"key":"21_CR72","doi-asserted-by":"publisher","first-page":"12336","DOI":"10.1038\/s41598-017-12101-3","volume":"7","author":"KC Hsu","year":"2017","unstructured":"Hsu KC, Hung HC, HuangFu WC et al (2017) Identification of neuraminidase inhibitors against dual H274Y\/I222R mutant strains. Sci Rep 7:12336","journal-title":"Sci Rep"},{"key":"21_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejmech.2019.05.076","volume":"178","author":"R Jia","year":"2019","unstructured":"Jia R, Zhang J, Ai W et al (2019) Design, synthesis and biological evaluation of \u201cMulti-Site\u201d-binding influenza virus neuraminidase inhibitors. Eur J Med Chem 178:64\u201380","journal-title":"Eur J Med Chem"},{"key":"21_CR74","doi-asserted-by":"publisher","first-page":"113097","DOI":"10.1016\/j.ejmech.2020.113097","volume":"212","author":"R Jia","year":"2021","unstructured":"Jia R, Zhang J, Bertagnin C et al (2021) Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity. Eur J Med Chem 212:113097","journal-title":"Eur J Med Chem"},{"key":"21_CR75","doi-asserted-by":"publisher","first-page":"112147","DOI":"10.1016\/j.ejmech.2020.112147","volume":"191","author":"W Ai","year":"2020","unstructured":"Ai W, Zhang J, Zalloum WA et al (2020) Discovery of novel \u201cdual-site\u201d binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors. Eur J Med Chem 191:112147","journal-title":"Eur J Med Chem"},{"key":"21_CR76","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ptr.6803","volume":"35","author":"HX Wang","year":"2021","unstructured":"Wang HX, Zeng MS, Ye Y et al (2021) Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase. Phytother Res 35:324\u2013336","journal-title":"Phytother Res"},{"key":"21_CR77","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1021\/acs.jmedchem.6b00537","volume":"59","author":"L Fu","year":"2016","unstructured":"Fu L, Bi Y, Wu Y et al (2016) Structure-based tetravalent zanamivir with potent inhibitory activity against drug-resistant influenza viruses. J Med Chem 59:6303\u20136312","journal-title":"J Med Chem"},{"key":"21_CR78","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1038\/s41467-020-19386-5","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Zhang B, Wang Y et al (2020) A universal dual mechanism immunotherapy for the treatment of influenza virus infections. Nat Commun 11:5597","journal-title":"Nat Commun"},{"key":"21_CR79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-1-4939-1292-6_38","volume":"1200","author":"N Sriwilaijaroen","year":"2014","unstructured":"Sriwilaijaroen N, Suzuki Y (2014) Molecular basis of a pandemic of avian-type influenza virus. Methods Mol Biol 1200:447\u2013480","journal-title":"Methods Mol Biol"},{"key":"21_CR80","doi-asserted-by":"publisher","first-page":"112357","DOI":"10.1016\/j.ejmech.2020.112357","volume":"199","author":"Y Yu","year":"2020","unstructured":"Yu Y, Qin HJ, Shi XX et al (2020) Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection. Eur J Med Chem 199:112357","journal-title":"Eur J Med Chem"},{"key":"21_CR81","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1021\/acsmedchemlett.0c00313","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Cheng LP, Pang W et al (2020) Design, synthesis, and biological evaluation of novel acylhydrazone derivatives as potent neuraminidase inhibitors. ACS Med Chem Lett 11:1745\u20131750","journal-title":"ACS Med Chem Lett"},{"key":"21_CR82","doi-asserted-by":"publisher","first-page":"e01526-18","DOI":"10.1128\/JVI.01526-18","volume":"93","author":"YQ Chen","year":"2019","unstructured":"Chen YQ, Lan LY, Huang M et al (2019) Hemagglutinin stalk-reactive antibodies interfere with influenza virus neuraminidase activity by steric hindrance. J Virol 93:e01526-18","journal-title":"J Virol"},{"key":"21_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/22221751.2019.1708214","volume":"9","author":"FF Xiong","year":"2020","unstructured":"Xiong FF, Liu XY, Gao FX et al (2020) Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection. Emerg Microbes Infect 9:78\u201387","journal-title":"Emerg Microbes Infect"},{"key":"21_CR84","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.aay0678","volume":"366","author":"D Stadlbauer","year":"2019","unstructured":"Stadlbauer D, Zhu X, McMahon M et al (2019) Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366:499\u2013504","journal-title":"Science"},{"key":"21_CR85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1743-422X-6-124","volume":"6","author":"N Sriwilaijaroen","year":"2009","unstructured":"Sriwilaijaroen N, Wilairat P, Hiramatsu H et al (2009) Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. Virol J 6:124","journal-title":"Virol J"},{"key":"21_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1521-4184(19995)332:5<151::AID-ARDP151>3.0.CO;2-E","volume":"332","author":"W Gottardi","year":"1999","unstructured":"Gottardi W (1999) Iodine and disinfection: theoretical study on mode of action, efficiency, stability, and analytical aspects in the aqueous system. Arch Pharm (Weinheim) 332:151\u2013157","journal-title":"Arch Pharm (Weinheim)"},{"issue":"Suppl 1","key":"21_CR87","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000089210","volume":"212","author":"H Ito","year":"2006","unstructured":"Ito H, Ito T, Hikida M et al (2006) Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology 212(Suppl 1):115\u2013118","journal-title":"Dermatology"},{"key":"21_CR88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-12-817890-4.00016-0","volume-title":"Phytochemicals as lead compounds for new drug discovery","author":"S Priyanka","year":"2020","unstructured":"Priyanka S, Gupta E, Neha M et al (2020) Chapter 16: Shikimic acid as intermediary model for the production of drugs effective against influenza virus. In: Egbuna C, Kumar S, Ifemeje JC, Ezzat SM, Kaliyaperumal S (eds) Phytochemicals as lead compounds for new drug discovery. Elsevier, pp 245\u2013256"},{"key":"21_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.foodchem.2010.12.031","volume":"127","author":"N Sriwilaijaroen","year":"2011","unstructured":"Sriwilaijaroen N, Kadowaki A, Onishi Y et al (2011) Mumefural and related HMF derivatives from Japanese apricot fruit juice concentrate show multiple inhibitory effects on pandemic influenza A (H1N1) virus. Food Chem 127:1\u20139","journal-title":"Food Chem"},{"key":"21_CR90","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.antiviral.2012.02.013","volume":"94","author":"N Sriwilaijaroen","year":"2012","unstructured":"Sriwilaijaroen N, Fukumoto S, Kumagai K et al (2012) Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1N1 viruses: its role in viral hemagglutination and neuraminidase inhibition. Antivir Res 94:139\u2013146","journal-title":"Antivir Res"},{"key":"21_CR91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","volume":"68","author":"JM Song","year":"2005","unstructured":"Song JM, Lee KH, Seong BL (2005) Antiviral effect of catechins in green tea on influenza virus. Antivir Res 68:66\u201374","journal-title":"Antivir Res"},{"key":"21_CR92","doi-asserted-by":"publisher","first-page":"8824934","DOI":"10.1155\/2020\/8824934","volume":"2020","author":"YS Kim","year":"2020","unstructured":"Kim YS, Li W, Kim JH et al (2020) Anti-influenza activity of an ethyl acetate fraction of a Rhus verniciflua ethanol extract by neuraminidase inhibition. Oxidative Med Cell Longev 2020:8824934","journal-title":"Oxidative Med Cell Longev"},{"key":"21_CR93","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1568026620666191219150738","volume":"20","author":"CS de Freitas","year":"2020","unstructured":"de Freitas CS, Rocha MEN, Sacramento CQ et al (2020) Agathisflavone, a biflavonoid from Anacardium occidentale L., inhibits influenza virus neuraminidase. Curr Top Med Chem 20:111\u2013120","journal-title":"Curr Top Med Chem"},{"key":"21_CR94","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.apsb.2020.04.001","volume":"10","author":"S Luo","year":"2020","unstructured":"Luo S, Guo L, Sheng C et al (2020) Rapid identification and isolation of neuraminidase inhibitors from mockstrawberry (Duchesnea indica Andr.) based on ligand fishing combined with HR-ESI-Q-TOF-MS. Acta Pharm Sin B 10:1846\u20131855","journal-title":"Acta Pharm Sin B"},{"key":"21_CR95","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1002\/jmv.26449","volume":"93","author":"P Li","year":"2021","unstructured":"Li P, Du R, Chen Z et al (2021) Punicalagin is a neuraminidase inhibitor of influenza viruses. J Med Virol 93:3465\u20133472","journal-title":"J Med Virol"},{"key":"21_CR96","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fmicb.2020.00182","volume":"11","author":"P Li","year":"2020","unstructured":"Li P, Du R, Wang Y et al (2020) Identification of chebulinic acid and chebulagic acid as novel influenza viral neuraminidase inhibitors. Front Microbiol 11:182","journal-title":"Front Microbiol"},{"key":"21_CR97","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1021\/jm901440f","volume":"53","author":"U Grienke","year":"2010","unstructured":"Grienke U, Schmidtke M, Kirchmair J et al (2010) Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J Med Chem 53:778\u2013786","journal-title":"J Med Chem"},{"key":"21_CR98","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12272-020-01230-5","volume":"43","author":"Y Lai","year":"2020","unstructured":"Lai Y, Yan Y, Liao S et al (2020) 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase. Arch Pharm Res 43:489\u2013502","journal-title":"Arch Pharm Res"},{"key":"21_CR99","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41589-019-0404-5","volume":"16","author":"HS Hahm","year":"2020","unstructured":"Hahm HS, Toroitich EK, Borne AL et al (2020) Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol 16:150\u2013159","journal-title":"Nat Chem Biol"}],"container-title":["Methods in Molecular Biology","Glycovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2635-1_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T14:11:26Z","timestamp":1666620686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2635-1_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071626344","9781071626351"],"references-count":99,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2635-1_21","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-0716-2635-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"30 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}